Glass Lewis Backs ECAT Board Nominees, Rejects Dissident Challenge
Event summary
- Glass Lewis recommended shareholders vote for all nine ECAT board nominees ahead of the June 9, 2026 annual meeting.
- ECAT's discount sat at 2.8% as of May 15, 2026, with a best-in-class distribution rate.
- Glass Lewis noted Saba Capital's failed third consecutive effort to rally investor support.
- ECAT has outperformed its peer group by 36% since 2023 with the lowest average discount to NAV.
The big picture
Glass Lewis' endorsement of ECAT's board nominees underscores the fund's strong performance metrics and effective discount management. The rejection of Saba Capital's nominees highlights the challenges activist investors face in rallying meaningful support without significant economic exposure. ECAT's 36% outperformance since 2023 positions it as a leader in the closed-end tactical allocation space, with implications for investor confidence and future fund flows.
What we're watching
- Governance Dynamics
- Whether ECAT's board can maintain shareholder-friendly policies amid ongoing dissident pressure.
- Performance Sustainability
- The pace at which ECAT can sustain its outperformance against peers in the tactical allocation category.
- Investor Sentiment
- How Saba Capital's reduced stake may impact its ability to influence future ECAT governance decisions.